nodes	percent_of_prediction	percent_of_DWPC	metapath
Vapreotide—TACR1—trigeminal nerve—peripheral nervous system neoplasm	0.134	0.226	CbGeAlD
Vapreotide—TACR1—vagus nerve—peripheral nervous system neoplasm	0.125	0.211	CbGeAlD
Vapreotide—TACR1—cranial nerve—peripheral nervous system neoplasm	0.0952	0.161	CbGeAlD
Vapreotide—SSTR2—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.0617	0.151	CbGpPWpGaD
Vapreotide—SSTR5—brainstem—peripheral nervous system neoplasm	0.0489	0.0826	CbGeAlD
Vapreotide—TACR1—nerve—peripheral nervous system neoplasm	0.0488	0.0824	CbGeAlD
Vapreotide—TACR1—ganglion—peripheral nervous system neoplasm	0.0482	0.0814	CbGeAlD
Vapreotide—SSTR2—brainstem—peripheral nervous system neoplasm	0.0315	0.0533	CbGeAlD
Vapreotide—SSTR5—cerebellum—peripheral nervous system neoplasm	0.0241	0.0407	CbGeAlD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.023	0.0564	CbGpPWpGaD
Vapreotide—TACR1—brainstem—peripheral nervous system neoplasm	0.0209	0.0354	CbGeAlD
Vapreotide—TACR1—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.0181	0.0444	CbGpPWpGaD
Vapreotide—SSTR2—cerebellum—peripheral nervous system neoplasm	0.0155	0.0263	CbGeAlD
Vapreotide—SSTR5—Peptide ligand-binding receptors—NTS—peripheral nervous system neoplasm	0.0117	0.0286	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—NTS—peripheral nervous system neoplasm	0.0108	0.0264	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.0086	0.0211	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—NTS—peripheral nervous system neoplasm	0.00849	0.0208	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00784	0.0192	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.00769	0.0188	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00723	0.0177	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.00663	0.0162	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.00608	0.0149	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00597	0.0146	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00572	0.014	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00569	0.0139	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00551	0.0135	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00528	0.0129	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	0.00525	0.0129	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.00522	0.0128	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.00495	0.0121	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—BDNF—peripheral nervous system neoplasm	0.00487	0.0119	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	0.00484	0.0119	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.00478	0.0117	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.00443	0.0108	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00434	0.0106	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00416	0.0102	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.00409	0.01	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.0039	0.00954	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.00387	0.00948	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.00386	0.00946	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	0.00381	0.00934	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.00357	0.00875	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00352	0.00862	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.00345	0.00846	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00337	0.00826	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00325	0.00796	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00311	0.00762	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00306	0.0075	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00294	0.00719	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00283	0.00692	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00271	0.00664	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.00268	0.00657	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00256	0.00627	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00256	0.00626	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.00247	0.00606	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.00247	0.00606	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00245	0.006	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	0.00243	0.00596	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00236	0.00578	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.00234	0.00574	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.00232	0.00568	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00222	0.00545	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.00216	0.0053	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.00214	0.00525	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.00214	0.00525	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00213	0.00522	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.0021	0.00514	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.00198	0.00484	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.00195	0.00477	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.00195	0.00477	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	0.0019	0.00465	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00186	0.00455	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.00181	0.00443	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.00173	0.00425	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.0017	0.00417	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.00169	0.00413	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.00167	0.00409	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.0016	0.00392	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	0.00156	0.00382	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.00156	0.00381	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.00152	0.00371	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.0014	0.00342	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.00138	0.00337	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.00137	0.00336	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.00132	0.00325	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.00131	0.00322	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.00127	0.00311	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.00127	0.0031	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.00127	0.0031	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	0.00126	0.00309	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.00126	0.00309	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.00122	0.00299	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.0012	0.00295	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.00117	0.00286	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.00111	0.00272	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.0011	0.0027	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.001	0.00245	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000996	0.00244	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000963	0.00236	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.00095	0.00233	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.000924	0.00226	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000919	0.00225	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000877	0.00215	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000874	0.00214	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000836	0.00205	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000813	0.00199	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000775	0.0019	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000772	0.00189	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.00075	0.00184	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000715	0.00175	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000711	0.00174	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.00069	0.00169	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000656	0.00161	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000608	0.00149	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000591	0.00145	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000563	0.00138	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000516	0.00126	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000503	0.00123	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000494	0.00121	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000464	0.00114	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000456	0.00112	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.00039	0.000956	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000368	0.000901	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000365	0.000895	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.00036	0.000882	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000359	0.000879	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000358	0.000876	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000354	0.000868	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000339	0.000831	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.00033	0.000808	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000327	0.000801	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000325	0.000795	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.0003	0.000734	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000297	0.000727	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000284	0.000695	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000277	0.000678	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000274	0.000671	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000267	0.000655	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.00026	0.000636	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000257	0.000631	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000255	0.000625	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000236	0.000578	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000227	0.000556	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000217	0.000532	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000216	0.000529	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.00021	0.000514	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000201	0.000492	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000201	0.000491	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.000192	0.00047	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.000177	0.000434	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000165	0.000404	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000158	0.000387	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.000139	0.000341	CbGpPWpGaD
